Get started
Author

James B.P. Barber

Observed names: Barber J, Barber Jbp., Barber, J, Barber, J.B., J Barber, J. B P. Barber, J. Barber, J.B. Barber, J.B.P. Barber, J.P. Barber, JBP Barber, James B.P Barber, W. Burrill, J. B. P. Barber, S. A. Rob
Observed institutions: National Health Service, Velindre NHS Trust, University of Manchester, MRC Clinical Trials Unit at UCL, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust, National Health Service Wales, Velindre Cancer Centre, University College London, Cardiff University
OpenAlex ID: A5113554203
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
2015 · Malcolm D. Mason, Wendy R. Parulekar, et al. · Journal of Clinical Oncology · 258
Heritability of Cellular Radiosensitivity: A Marker of Low-Penetrance Predisposition Genes in Breast Cancer?
1999 · S.A. Roberts, A.R. Spreadborough, et al. · The American Journal of Human Genetics · 197
Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition?
1998 · D Scott, JBP Barber, et al. · British Journal of Cancer · 165
PDF
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
2013 · S Nicholson, E Hall, et al. · British Journal of Cancer · 137
PDF
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer
2000 · James B.P Barber, Wayne Burrill, et al. · Radiotherapy and Oncology · 136
Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients
2003 · S. Quarmby, H. Fakhoury, et al. · International Journal of Radiation Biology · 117
Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy
1997 · JM Appleby, JBP Barber, et al. · British Journal of Cancer · 83
PDF
Surgery versus radiotherapy for muscle invasive bladder cancer
2001 · Mike Shelley, J Barber, et al. · Cochrane Database of Systematic Reviews · 79
PDF
A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients
1999 · Anne E. Kiltie, Anderson J. Ryan, et al. · Radiotherapy and Oncology · 63
Detection of Individual Differences in Radiation-Induced Apoptosis of Peripheral Blood Lymphocytes in Normal Individuals, Ataxia Telangiectasia Homozygotes and Heterozygotes, and Breast Cancer Patients after Radiotherapy
2000 · J. B P. Barber, C. M L. West, et al. · Radiation Research · 54
Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay
2000 · W. Burrill, J. B. P. Barber, S. A. Rob · International Journal of Radiation Biology · 45
A Meta-analysis of Randomised Trials Suggests a Survival Benefit for Combined Radiotherapy and Radical Cystectomy Compared with Radical Radiotherapy for Invasive Bladder Cancer: Are These Data Relevant to Modern Practice?
2003 · M.D. Shelley, T.J. Wilt, et al. · Clinical Oncology · 30
Bladder Preservation in Small Cell Carcinoma of the Urinary Bladder: An Institutional Experience and Review of the Literature
2006 · J.F. Lester, E. Hudson, et al. · Clinical Oncology · 26
Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients
1999 · Anne E Kiltie, James B.P Barber, et al. · International Journal of Radiation Oncology*Biology*Physics · 16
Clinical oncologists favour radical radiotherapy for localized prostate cancer: a questionnaire survey
2002 · C.L. Hanna, M.D. Mason, et al. · British Journal of Urology · 13
A Phase II Trial of Continuous 5-Fluorouracil in Recurrent or Metastatic Transitional Cell Carcinoma of the Urinary Tract
2009 · M.S. Highley, G.O. Griffiths, et al. · Clinical Oncology · 12
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice
2016 · J.S. Tanguay, C. Catlow, et al. · Clinical Oncology · 9
Correspondence
2003 · M.D Shelley, J Barber, et al. · Clinical Oncology · 8
Chromosomal radiosensitivity and cancer predisposition
2000 · AM Scott, SA Roberts, et al. · Research Explorer (The University of Manchester) · 8
Radiotherapy after Radical Prostatectomy for Adenocarcinoma of the Prostate: a UK Institutional Experience and Review of Published Studies
2008 · E. Hudson, H. Kynaston, et al. · Clinical Oncology · 5
Open-label phase II study of ZD0473 in patients with metastatic hormone refractory prostate cancer
2001 · C. Tyrrell, S. Bullard, et al. · European Journal of Cancer · 4
Ten Years on the Juggernaut Keeps on Rolling: Comments on the STAMPEDE Trial from the Front Line
2016 · A. Birtle, J. Barber · Clinical Oncology · 2
PDF
7110 POSTER DISCUSSION A Phase II Trial of Docetaxel, Cisplatin, 5-Fluorouracil (TPF) in Locally Advanced and Metastatic Carcinoma of the Penis (CRUK/09/001)
2011 · A. Bahl, S. Nicholson, et al. · European Journal of Cancer · 2
1042P Quality of Life (QoL) and updated efficacy outcomes of first-line single-agent cemiplimab in advanced penile carcinoma: The EPIC-B UK multicenter study
2025 · A. Challapalli, P. White, et al. · Annals of Oncology
1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform
2022 · S.J. Crabb, L. Dempsey, et al. · Annals of Oncology
PDF
Works count: 35
Citation count: 1,469
H-index: 14
I10-index: 16
Year
Topic
Type